- Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver Transplantation.
Zori AG, Ismael MN, Limaye AR, Firpi R, Morelli G, Soldevila-Pico C, Suman A, Vogel JD, Lazarowicz M, Geller BS, Toskich B, Gonzalo DH, Johnson MW, Cabrera R.
Am J Clin Oncol. 2020 Feb 7; PMID: 32079854. - Thermal ablation versus wedge or segmental resection in patients with early stage hepatocellular carcinoma: a population survival analysis.
Kolarich AR, Cabrera R, Hughes SJ, George TJ Jr, Geller BS, Grajo JR.
HPB (Oxford); 2019 Feb; PMID: 30057124. - Safety of Radioembolization in the Setting of Angiographically Apparent Arterioportal Shunting.
Thornton LM, Geller BS, Pepin EW, Shah JL, Kapp M, Toskich BB.
J Vasc Interv Radiol. 2018 Nov; PMID: 30293727. - Disruption of mesoderm formation during cardiac differentiation due to developmental exposure to 13-cis-retinoic acid.
Liu Q, Van Bortle K, Zhang Y, Zhao MY, Zhang Z, Geller BS, Gruber JJ, Jiang C, Wu JC, Snyder MP.
Sci Rep. 2018 Aug 28; PMID: 30154523. - Non-surgical management of patients with intrahepatic cholangiocarcinoma in the United Sates, 2004-2015: an NCBD analysis.
Kolarich AR, Shah JL, George TJ Jr, Hughes SJ, Shaw CM, Geller BS, Grajo JR.
J Gastrointest Oncol. 2018 June; PMID: 29998019.